Analysts See $-0.08 EPS for Limoneira Company (LMNR)

December 8, 2017 - By Hazel Jackson

 Analysts See $ 0.08 EPS for Limoneira Company (LMNR)
Investors sentiment increased to 2.21 in 2017 Q2. Its up 0.86, from 1.35 in 2017Q1. It is positive, as 3 investors sold Limoneira Company shares while 11 reduced holdings. 10 funds opened positions while 21 raised stakes. 3.24 million shares or 6.35% more from 3.04 million shares in 2017Q1 were reported.
Morgan Stanley reported 0% of its portfolio in Limoneira Company (NASDAQ:LMNR). Moreover, Legal & General Grp Public Ltd has 0% invested in Limoneira Company (NASDAQ:LMNR). Schwab Charles Invest Mngmt owns 40,677 shares or 0% of their US portfolio. Zacks Mgmt holds 0.03% of its portfolio in Limoneira Company (NASDAQ:LMNR) for 52,535 shares. Moreover, Rhumbline Advisers has 0% invested in Limoneira Company (NASDAQ:LMNR) for 13,838 shares. Royal National Bank Of Canada reported 6,630 shares. Moreover, State Of New Jersey Common Pension Fund D has 0.02% invested in Limoneira Company (NASDAQ:LMNR) for 216,000 shares. Sfe Invest Counsel reported 25,513 shares stake. American International Grp Inc accumulated 7,410 shares or 0% of the stock. Wells Fargo Mn holds 9,093 shares. First Interstate Savings Bank holds 0.12% or 25,000 shares. Amer Research & Com stated it has 0.03% of its portfolio in Limoneira Company (NASDAQ:LMNR). Comml Bank Of America Corp De reported 22,153 shares stake. California Pub Employees Retirement Systems has invested 0% in Limoneira Company (NASDAQ:LMNR). Toronto Dominion State Bank reported 3,000 shares stake.

Analysts expect Limoneira Company (NASDAQ:LMNR) to report $-0.08 EPS on January, 9.They anticipate $0.02 EPS change or 33.33 % from last quarter’s $-0.06 EPS. After having $0.52 EPS previously, Limoneira Company’s analysts see -115.38 % EPS growth. The stock decreased 4.85% or $1.13 during the last trading session, reaching $22.16. About 79,243 shares traded or 154.57% up from the average. Limoneira Company (NASDAQ:LMNR) has risen 20.88% since December 8, 2016 and is uptrending. It has outperformed by 4.18% the S&P500.

Limoneira Company (NASDAQ:LMNR) Ratings Coverage

Among 4 analysts covering Limoneira (NASDAQ:LMNR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Limoneira had 5 analyst reports since September 10, 2015 according to SRatingsIntel. The stock of Limoneira Company (NASDAQ:LMNR) earned “Buy” rating by Lake Street on Wednesday, January 11. TH Capital maintained it with “Buy” rating and $25 target in Thursday, September 10 report. The rating was maintained by Roth Capital with “Buy” on Wednesday, June 7. As per Thursday, September 10, the company rating was maintained by Roth Capital. As per Monday, October 19, the company rating was initiated by Buckingham Research.

Limoneira Company operates as an agribusiness and real estate development firm in the United States and internationally. The company has market cap of $319.22 million. The firm operates through four divisions: Lemon Operations, Other Agribusiness, Rental Operations, and Real Estate Development. It has a 38.08 P/E ratio. The Lemon Operations segment grows, processes, packs, markets, and sells lemons directly to food service, wholesale, and retail customers, as well as packs lemons grown by others.

More notable recent Limoneira Company (NASDAQ:LMNR) news were published by: which released: “Limoneira Company Announces Third Quarter Fiscal Year 2017 Financial Results” on September 11, 2017, also with their article: “Limoneira Appoints Mark Palamountain as Chief Financial Officer” published on December 05, 2017, published: “Limoneira and Tesla Power up to Save Energy Costs” on May 22, 2017. More interesting news about Limoneira Company (NASDAQ:LMNR) were released by: and their article: “Harvest at Limoneira – A Master Planned New Community Breaks Ground” published on November 09, 2017 as well as‘s news article titled: “Limoneira Company Announces Formation of Limoneira Lewis Community Builders …” with publication date: November 16, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.